Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KAPA

Kairos Pharma Ltd

May 29 • 04:00PM ET

0.5094

-0.0176 -3.34 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: APRE BCDA BIVI CALC CVM GOVX KPRX NEUP AIM JAGX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	40.92%	Shs Outstand	21.41M	Perf Week	-7.85%
Market Cap	10.90M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.00%	Shs Float	12.65M	Perf Month	-7.72%
Enterprise Value	7.23M	PEG	-	EPS next Q	-0.08	Inst Own	2.81%	Short Float	0.96%	Perf Quarter	-15.87%
Income	-5.84M	P/S	-	EPS this Y	-23.33%	Inst Trans	-6.92%	Short Ratio	0.82	Perf Half Y	-30.60%
Sales	0.00M	P/B	2.05	EPS next Y	-81.08%	ROA	-85.36%	Short Interest	0.12M	Perf YTD	-28.25%
Book/sh	0.25	P/C	2.97	EPS next 5Y	-	ROE	-93.84%	52W High	2.11 -75.86%	Perf Year	-7.73%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-53.52% -29.30%	ROIC	-109.90%	52W Low	0.40 27.35%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.71% 8.38%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-17.50%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.31	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.38	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.31	EPS Q/Q	1.01%	SMA20	-2.48%	Beta	1.41	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-10.48%	Rel Volume	0.85	Prev Close	0.53
Employees	4	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-40.12%	Avg Volume	147.89K	Price	0.51
IPO	Sep 16, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-274.33% -	Trades		Volume	125,990	Change	-3.34%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)